<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">342432</id>
  <title nil="true"/>
  <common-name>5-[(2-ethylquinazolin-4-yl)oxymethyl]-3-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-1,3,4-oxadiazole-2-thione</common-name>
  <description>5-[(2-ethylquinazolin-4-yl)oxymethyl]-3-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-1,3,4-oxadiazole-2-thione is a chemical compound with the formula C25H28N6O2S. It has an average molecular weight of 476.60 g/mol.</description>
  <cas>96546-96-2</cas>
  <pubchem-id>57099</pubchem-id>
  <chemical-formula>C25H28N6O2S</chemical-formula>
  <weight>476.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T03:22:47Z</created-at>
  <updated-at type="dateTime">2026-08-31T03:22:47Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCC1=NC2=CC=CC=C2C(=N1)OCC3=NN(C(=S)O3)CN4CCN(CC4)C5=CC=C(C=C5)C</moldb-smiles>
  <moldb-formula>C25H28N6O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C25H28N6O2S/c1-3-22-26-21-7-5-4-6-20(21)24(27-22)32-16-23-28-31(25(34)33-23)17-29-12-14-30(15-13-29)19-10-8-18(2)9-11-19/h4-11H,3,12-17H2,1-2H3</moldb-inchi>
  <moldb-inchikey>BSURCHUTWLVWTA-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">476.1994453</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM338325</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-[(2-ethylquinazolin-4-yl)oxymethyl]-3-[[4-(4-methylphenyl)piperazin-1-yl]methyl]-1,3,4-oxadiazole-2-thione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0292823</sync-id>
  <structure-inchikey>BSURCHUTWLVWTA-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2080004000000000008002800000000000000000500000000000004a000800000000000000802004004100000000000000010000000000000000000000000000000000000000000000800000010100000000000040000000000000000000000000000000001000000004020100000000000000000000000800000040002000804010000000000000000000000102000000000000000000400000000000000000140000080000040000000000080000008000000800000200000000040000080800000000000004001000000000042000000200000000010100000140000001000040000002000080000000080000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:42:04Z</structure-indexed-at>
</compound>
